Related Experiment Video
Updated: Feb 28, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Pathogenic Drivers of Difficult-to-Treat Rheumatoid Arthritis: Synovium and Beyond
András Miklós Dorgó1, Lilla Gunkl-Tóth1,2,3, György Nagy1,4,5
1Department of Rheumatology and Immunology, Semmelweis University, 1023 Budapest, Hungary.
Abstract:
Difficult-to-treat (D2T) rheumatoid arthritis (RA) remains a major clinical challenge, affecting a significant proportion of patients who experience persistent symptoms despite multiple therapeutic regimens. This narrative review provides a comprehensive overview of potential molecular and cellular mechanisms that may underlie the D2T RA phenotype. We synthesize evidence across a broad biological landscape-the role of genetic and epigenetic factors, autoantibodies, and diverse immune cell subsets is detailed in the context of therapeutic resistance. Furthermore, we examine the potential role of synovial signatures and stromal cell-mediated pathways, which may drive chronicity independently of traditional immune targets. The review highlights the complex interplay of peripheral and central determinants that contribute to patient-reported outcomes such as pain. We also discuss comorbid conditions, environmental factors such as smoking and nutrition, and treatment-related factors relevant to the D2T population. By integrating these aspects, this work aims to facilitate better stratification and the identification of novel therapeutic targets for refractory disease.
Insights
Difficult-to-treat rheumatoid arthritis (RA) involves complex factors beyond standard treatments. Understanding genetic, immune, and environmental influences is key to identifying new therapies for refractory RA.
Area of Science:
- Rheumatology
- Immunology
- Genetics
Background:
- Difficult-to-treat rheumatoid arthritis (D2T RA) presents persistent symptoms despite various therapies.
- This condition poses a significant clinical challenge, impacting a substantial patient subset.
Purpose of the Study:
- To provide a comprehensive review of molecular and cellular mechanisms underlying D2T RA.
- To explore factors contributing to therapeutic resistance in rheumatoid arthritis.
Main Methods:
- Narrative review synthesizing evidence on genetic, epigenetic, and immune factors.
- Examination of synovial signatures, stromal cell pathways, and central determinants.
- Inclusion of comorbid, environmental, and treatment-related factors.
Main Results:
- D2T RA is influenced by a complex interplay of genetic, epigenetic, autoantibody, and immune cell factors.
- Synovial and stromal cell pathways may drive chronicity independently of traditional targets.
- Peripheral and central determinants, comorbidities, and environmental factors impact outcomes.
Conclusions:
- A multifaceted approach is needed to understand and treat D2T RA.
- Better patient stratification and novel therapeutic targets can be identified by integrating diverse biological and clinical data.
- Addressing complex factors is crucial for managing refractory rheumatoid arthritis.
More Related Videos
09:18Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
The JAK-STAT Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...